3. Contraception Flashcards
Fraser guidelines for prescribing contraceptives to under 16’s
- She understands the doctor’s advice
- She cannot be persuaded to inform her parents
- She is very likely to continue having sex
- Her mental and physical health will suffer without contraception
- In her best interests to provide treatment
Types of combined -contraception
ORAL
* oestrogen (ethinylesteradiol, estradiol ect) AND progestogen (desogestrel, noresthisterone, levonorgestrel, nomegestrel)
TRANSDERMAL PATCH
* Evra patches (norelgestromin with ethinylestradiol)
VAGINAL RING
* Nuva ring (etongestrel with ethinylestradiol)
-strel = progestogen
Types of progestogren only contraceptives
ORAL
* desogestrel
* norethisterone
* levonorgestrel
PARENTERAL
* medroxyprogesterone (injection)
* Noresthisterone (injection)
* Etonogestrel (implant)
INTRAUTERINE DEVICE
* Levonorgestrel
Combined oral contraceptives mechansim of action
Inhibit ovulation
Combined oral contraceptives dosing and counselling
A menstrual bleed is caused by the shedding of the uterine lining as the uterine lining remains thin in females take COC, the patient’s menstrual period will not occur.
Take one tablet daily for 3 weeks + 1 week pill-free interval for withdrawal bleeding.
withdrawl bleeding is not a real period, the bleeding is induced by the drop in progestogen
Can begin anytime in menstrual cycle, if started on day 6 or after, use protection for 7 days.
Cannot be used by women older than 50 years, due to the increased risk of VTE.
Types of COC preparations
- Monophasic (fixed amount of oestrogen and progestogen)
- Phasic (varying amount of oestrogen and progestogen to mimic a normal menstrual cycle ). For women who do not have withdrawal bleeds or have breakthrough bleeds with monophasic preparations
- Every day prepation (pill-fre days replaced with inactive pills)
4.Low-stregnth oestrogen preparations (~20mg ethinylestradiol)
Used in women with a risk factor for circulatory disease, as they are at greater risk of VTE
COC risks
Risk of VTE
factors that increase risk further
* Obesity: BMI > 30
* Smoking
* Primary relative under 45 with VTE
* Immobilisation
* Age >35 years
* Type of progestofen: desogestrel, gestodene, drosperinone
Risk of arterial thromboembolism
factors that increase risk further
* diabetes mellitus
* hypertension
* migraine without aura
AVOID COC if 2 more mORE RISK FACTORS PRESENT
Combined oral contraceptives and surgery
Combined oral contraceptives should be stopped 4 weeks before major elective surgery.
For surgery to the legs or surgery that results in prolonged lower limb immobilisation:
- can switch to progestogen-only contraceptives as it is the oestrogen content that increases risk of VTE
- restart contraceptives on the first menses, at least 2 weeks following full mobilization
If surgery was not planned
- thromboprophylaxis with heparin and graduated compression hoisery can be used
These restrictions do not apply to minor surger with short duration anasthesia, e.g tooth extraction.
Also does not apply to women on oestrogen-free contraceptives
Combined oral contraceptives and travel
Can reduce risk of VTE with compression stocking and leg exercises
Signs of VTE
- Sudden severe chest pain, breathlessness, cough with blood-stained sputum PULMONARY EMBOLISM
- Unexplained swelling or severe pain in calf of one leg DEEP VEIN THROMBOSIS
- Serious neurological effects such as severe polonged headache, slurred speech, dysphagia, motor disturbances STROKE
The oestrogen component of combined oral contraceptives is responsible f
Combined oral contraceptives and oestrogen containing HRT risks
COC’s and oestrogen containing HRT occasionally cause liver dysfunction (jaundice, hepatitis, liver enlargement)
COC’s and oestrogen containing HRT may also cause an increase in blood pressure. SHOULD BE STOPPED if systolic goes above 160mmHg or disastolic goes above 95mmHg
Also increase the risk of breast and cervical cancer. BUT decrease risk of ovarian, colorectal and endometrial cancer.
Also reduce dysmennorrhea, menorrhagia, symptomatic fibroids and cysts
Combined oral contraceptives contraindications
Combined oral contraceptives should be stopped if a patient has a risk factor that contraindicates treatment:
- Smoking > 40 cigarettes
- History of arterial or venous thrombus
- Migraine/severe migraine lasting >72 hrs, migraine treated with ergot derivatives
- Diabetes mellitus with complications
- BMI >35
- Over 50 years
- Transient iscaemic attack
- Hypertension; systolic >160mmHg and diastolic >95mmHg
Progestogen-only pill (POP) mechanism of action
Prevents pregnancy by thickening the mucus in the cervix to stop sperm reaching an egg
Menstrual irregularities, heavy or light periods is common
Progestogen-only pill (POP) dosing regimen
One tablet is taken daily on a continuous basis, starting on day 1 and taken at the same time each day .
If the regimen is started after day 5 of the menstrual cycle, additional precuation must be used for 2 days, such as a condom
Progestogen-only pill (POP) risks
Increase the risk of breast cancer